Home / Tag Archives: Nasdaq: EGLT

Tag Archives: Nasdaq: EGLT

News Alert: Egalet Corporation (Nasdaq: EGLT)

Egalet Corporation (Nasdaq: EGLT) (“Egalet” or the “Company”), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing innovative treatments for pain and other conditions, recently declared the pricing of its underwritten public offering of 16,666,667 shares of its common stock and accompanying warrants to purchase up to …

Read More »